Immunotherapy — harnessing T-cells to attack cancer cells in the body — has given hope to patients who endure round
Month: October 2018
Robotic arm may help to rehabilitate chronic stroke victims, finds new study
New York, NY – New research published in Frontiers in Neurology finds that robotic arm rehabilitation in chronic stroke patients
Radiation therapy cuts low risk of recurrence by nearly 3/4 for patients with ‘good risk’
A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but
Aggressive treatment for some stage IV lung cancer pts can dramatically improve OS
Adding radiation therapy or surgery to systemic therapy for stage IV lung cancer patients whose cancer has spread to a
Long-term side effects similarly low for weekly, conventional breast radiation, trial finds
In a 10-year study of women who received radiation therapy to treat early-stage breast cancer, those receiving fewer, larger individual
Imaging collaboration sheds new light on cancer growth
Walter and Eliza Hall Institute researchers have uncovered new insights into how the normal controls on cell growth are lost
Virus production boosted in cells to generate more vectors for gene transfer
Researchers at Tokyo Medical and Dental University (TMDU) have established a method to increase the released lentiviral particles produced by
Eye-tracking glasses provide a new vision for the future of augmented reality
Battery-free eye-tracking glasses developed at Dartmouth College could create an even more realistic experience for augmented reality enthusiasts. The new
Opioid-affected births to rural residents increase in rural and urban hospitals
The opioid epidemic has had devastating effects on families in rural communities, places where both maternity care and substance use
Hormone-blocking injections reduce early menopause from breast cancer treatment
Final results of SWOG Cancer Research Network’s groundbreaking international Prevention of Early Menopause Study (POEMS) clinical trial are in, and
